Durable memory responses against cancer observed in 1⁄4 of mice in the combination therapy group in our model correlated with a significant increase in CD8+ T cells at the tumor implantation site in tumor rechallenged mice as compared with naïve mice challenged with tumors for the first time. Here, CD8A is linked to cancer.